ZNF679: A Potential Drug Target and Biomarker (G168417)
ZNF679: A Potential Drug Target and Biomarker
ZNF679 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZNF family of proteins, which are known for their role in regulating gene expression and cell growth. ZNF679 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ZNF679 has become a focus of interest for researchers looking for new treatments for these conditions.
The ZNF679 Protein
ZNF679 is a 21-kDa protein that is expressed in a variety of tissues in the body. It is highly conserved, with a calculated pI of 4.87 and a predicted monomeric molecular weight of 67.9 kDa. ZNF679 has four known functions, including:
1. Regulation of stem cell proliferation: ZNF679 has been shown to regulate the self-renewal ability of stem cells, which are a critical component of tissue repair and regeneration.
2. Control of cell proliferation: ZNF679 has been shown to play a role in controlling cell proliferation, by regulating the activity of the cell cycle regulator, p21.
3. Regulation of gene expression: ZNF679 has been shown to regulate the expression of various genes, including those involved in cell adhesion, migration, and invasion.
4. Maintenance of neural stem cell stemness: ZNF679 has been shown to maintain the stemness of neural stem cells, by regulating their ability to differentiate into neurons.
Drug Target Potential
The potential drug targets for ZNF679 are numerous, due to its involvement in various cellular processes that are important for human health. Some potential drug targets include:
1. Cancer: ZNF679 has been shown to be involved in the development and progression of various cancers, including breast, ovarian, and colorectal cancers. Therefore, targeting ZNF679 may be a promising approach to treating these cancers.
2. Neurodegenerative diseases: ZNF679 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Therefore, targeting ZNF679 may be a promising approach to treating these conditions.
3. Autoimmune disorders: ZNF679 has been shown to be involved in the development and progression of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. Therefore, targeting ZNF679 may be a promising approach to treating these conditions.
Biomarker Potential
ZNF679 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, ZNF679 has been shown to be elevated in the blood of patients with breast cancer, and may be a useful biomarker for monitoring disease progression. Similarly, ZNF679 has been shown to be elevated in the urine of patients with neurodegenerative diseases, and may be a useful biomarker for monitoring disease progression. Finally, ZNF679 has been shown to be elevated in the blood of patients with autoimmune disorders, and may be a useful biomarker for monitoring disease activity.
Conclusion
In conclusion, ZNF679 is a protein that has been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a result, ZNF679 has become a focus of interest for researchers looking for new treatments for these conditions. Further research is needed to fully understand the role of ZNF679 in these diseases, and to develop effective therapies that target this protein.
Protein Name: Zinc Finger Protein 679
Functions: May be involved in transcriptional regulation
The "ZNF679 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF679 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1
